Wuthering Waves is geared up for the first anniversary with the Version 2.3 Phase 2. It will launch on May 22, 2025. The update will introduce Ciaccona, a 5-star Aero Resonator and some fan ...

Registered candidates can now access their hall tickets on official website. MET 2025 Phase 2 Admit Card: The Manipal Academy of Higher Education (MAHE) has officially released the admit card for ...

Quantum Biopharma plans to file an application by year's end seeking FDA clearance for a Phase 2 clinical trial testing Lucid ...

In the Phase 2 open-label study, REC-4881 (4 mg QD) led to a median 43% reduction (n=6 patients) in polyp burden at the Week 13 assessment at time of data cutoff. Five of six patients (83% ...

With two weeks in the books, the Bills have moved into Phase 2, inching closer to actual football activity. While Phase 1 consisted only of "meetings, strength and conditioning, and physical ...

Alzamend to launch five Phase 2 trials of AL001, including PTSD and bipolar disorder, starting Q3 and Q4 of 2025. Get our list of 10 overlooked stocks—including one paying a 9% dividend—before ...

Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis knee pain. The Big Pharma company discontinued the study testing intra ...

Alkeus Pharmaceuticals reveals promising Phase 2 SAGA study results, showing gildeuretinol slows vision decline in geographic ...

PHILADELPHIA and VANCOUVER, British Columbia, April 16, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the ...

Data from Beacon’s interim six-month safety and efficacy results from a phase 2, announced May 6, pointed to improvements across “several key measures” of visual function, the private ...

AEEE 2025 phase 2 slot booking: The Amrita Vishwa Vidyapeetham has officially commenced the slot booking process for the second phase of the Amrita Entrance Examination – Engineering (AEEE ...

"With these compelling Phase 2 data, we are moving full speed into Phase 3 planning and FDA discussions,” said Chuck Bramlage, Chief Executive Officer of Yamo Pharmaceuticals. "Our mission is clear: ...